- Home
- VMAR vs QLGN Comparison
VMAR vs QLGN Comparison
Compare VMAR & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- QLGN
- Stock Information
- Founded
- VMAR 1995
- QLGN 1996
- Country
- VMAR Canada
- QLGN United States
- Employees
- VMAR N/A
- QLGN N/A
- Industry
- VMAR Marine Transportation
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- QLGN Health Care
- Exchange
- VMAR Nasdaq
- QLGN Nasdaq
- Market Cap
- VMAR 2.3M
- QLGN 2.4M
- IPO Year
- VMAR 2020
- QLGN N/A
- Fundamental
- Price
- VMAR $0.86
- QLGN $3.55
- Analyst Decision
- VMAR Strong Buy
- QLGN
- Analyst Count
- VMAR 1
- QLGN 0
- Target Price
- VMAR $270.00
- QLGN N/A
- AVG Volume (30 Days)
- VMAR 1.8M
- QLGN 110.9K
- Earning Date
- VMAR 04-14-2025
- QLGN 04-07-2025
- Dividend Yield
- VMAR N/A
- QLGN N/A
- EPS Growth
- VMAR N/A
- QLGN N/A
- EPS
- VMAR N/A
- QLGN N/A
- Revenue
- VMAR $2,105,869.00
- QLGN N/A
- Revenue This Year
- VMAR $120.43
- QLGN N/A
- Revenue Next Year
- VMAR N/A
- QLGN N/A
- P/E Ratio
- VMAR N/A
- QLGN N/A
- Revenue Growth
- VMAR N/A
- QLGN N/A
- 52 Week Low
- VMAR $0.83
- QLGN $2.96
- 52 Week High
- VMAR $110.70
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- VMAR 30.15
- QLGN 47.06
- Support Level
- VMAR $1.07
- QLGN $3.16
- Resistance Level
- VMAR $1.19
- QLGN $3.75
- Average True Range (ATR)
- VMAR 0.11
- QLGN 0.21
- MACD
- VMAR -0.01
- QLGN 0.06
- Stochastic Oscillator
- VMAR 6.24
- QLGN 67.25
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.